AKBA logo

Akebia Therapeutics (AKBA) Net income

annual net income:

-$69.41M-$17.48M(-33.67%)
December 31, 2024

Summary

  • As of today (July 1, 2025), AKBA annual net profit is -$69.41 million, with the most recent change of -$17.48 million (-33.67%) on December 31, 2024.
  • During the last 3 years, AKBA annual net income has risen by +$212.61 million (+75.39%).
  • AKBA annual net income is now -746.88% below its all-time high of -$8.20 million, reached on December 31, 2012.

Performance

AKBA Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

quarterly net income:

$6.11M+$28.92M(+126.80%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKBA quarterly net profit is $6.11 million, with the most recent change of +$28.92 million (+126.80%) on March 31, 2025.
  • Over the past year, AKBA quarterly net income has increased by +$24.10 million (+133.98%).
  • AKBA quarterly net income is now -79.25% below its all-time high of $29.45 million, reached on June 30, 2022.

Performance

AKBA quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

TTM net income:

-$45.31M+$24.10M(+34.72%)
March 31, 2025

Summary

  • As of today (July 1, 2025), AKBA TTM net profit is -$45.31 million, with the most recent change of +$24.10 million (+34.72%) on March 31, 2025.
  • Over the past year, AKBA TTM net income has dropped by -$2.28 million (-5.30%).
  • AKBA TTM net income is now -7197.95% below its all-time high of -$620.90 thousand, reached on March 31, 2013.

Performance

AKBA TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

AKBA Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.7%+134.0%-5.3%
3 y3 years+75.4%+109.8%+83.5%
5 y5 years+75.2%+110.1%+88.3%

AKBA Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-33.7%+75.4%-79.3%+111.3%-12.0%+72.1%
5 y5-year-33.7%+82.0%-79.3%+103.5%-12.0%+88.5%
alltimeall time-746.9%+82.0%-79.3%+103.5%-7197.9%+88.5%

AKBA Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
$6.11M(-126.8%)
-$45.31M(-34.7%)
Dec 2024
-$69.41M(+33.7%)
-$22.80M(+13.8%)
-$69.41M(+50.9%)
Sep 2024
-
-$20.04M(+133.5%)
-$45.99M(+13.7%)
Jun 2024
-
-$8.58M(-52.3%)
-$40.44M(-6.0%)
Mar 2024
-
-$17.98M(-3029.2%)
-$43.03M(-17.1%)
Dec 2023
-$51.92M(-44.9%)
$614.00K(-104.2%)
-$51.92M(-11.4%)
Sep 2023
-
-$14.49M(+29.7%)
-$58.61M(-40.3%)
Jun 2023
-
-$11.17M(-58.4%)
-$98.22M(+70.5%)
Mar 2023
-
-$26.88M(+342.7%)
-$57.59M(-38.2%)
Dec 2022
-$94.23M(-66.6%)
-$6.07M(-88.8%)
-$93.14M(-40.6%)
Sep 2022
-
-$54.10M(-283.7%)
-$156.93M(-3.4%)
Jun 2022
-
$29.45M(-147.2%)
-$162.38M(-40.9%)
Mar 2022
-
-$62.42M(-10.7%)
-$274.87M(-2.5%)
Dec 2021
-$282.02M(-26.7%)
-$69.86M(+17.3%)
-$282.02M(-6.2%)
Sep 2021
-
-$59.54M(-28.3%)
-$300.55M(-0.1%)
Jun 2021
-
-$83.04M(+19.3%)
-$300.96M(-23.6%)
Mar 2021
-
-$69.58M(-21.3%)
-$393.67M(+2.3%)
Dec 2020
-$384.84M(+37.6%)
-$88.38M(+47.4%)
-$384.84M(-1.6%)
Sep 2020
-
-$59.96M(-65.9%)
-$390.94M(+1.4%)
Jun 2020
-
-$175.75M(+189.3%)
-$385.57M(+43.9%)
Mar 2020
-
-$60.75M(-35.7%)
-$267.99M(-4.2%)
Dec 2019
-$279.66M(+94.8%)
-$94.48M(+73.1%)
-$279.66M(+14.0%)
Sep 2019
-
-$54.59M(-6.2%)
-$245.23M(+13.2%)
Jun 2019
-
-$58.17M(-19.7%)
-$216.69M(+12.5%)
Mar 2019
-
-$72.42M(+20.6%)
-$192.59M(+34.1%)
DateAnnualQuarterlyTTM
Dec 2018
-$143.59M(+94.9%)
-$60.05M(+130.6%)
-$143.59M(+111.1%)
Sep 2018
-
-$26.05M(-23.5%)
-$68.01M(+4.5%)
Jun 2018
-
-$34.07M(+45.5%)
-$65.10M(+23.9%)
Mar 2018
-
-$23.42M(-250.9%)
-$52.55M(-28.7%)
Dec 2017
-$73.67M(-45.7%)
$15.52M(-167.1%)
-$73.67M(-42.0%)
Sep 2017
-
-$23.13M(+7.5%)
-$127.06M(-9.4%)
Jun 2017
-
-$21.52M(-51.7%)
-$140.23M(-9.2%)
Mar 2017
-
-$44.54M(+17.6%)
-$154.49M(+13.8%)
Dec 2016
-$135.75M(+123.6%)
-$37.86M(+4.3%)
-$135.75M(+15.3%)
Sep 2016
-
-$36.31M(+1.5%)
-$117.74M(+16.7%)
Jun 2016
-
-$35.78M(+38.7%)
-$100.91M(+33.1%)
Mar 2016
-
-$25.80M(+29.9%)
-$75.82M(+24.9%)
Dec 2015
-$60.72M(+63.9%)
-$19.86M(+2.0%)
-$60.72M(+18.5%)
Sep 2015
-
-$19.48M(+82.2%)
-$51.23M(+24.6%)
Jun 2015
-
-$10.69M(-0.1%)
-$41.10M(+8.1%)
Mar 2015
-
-$10.70M(+3.1%)
-$38.03M(+2.7%)
Dec 2014
-$37.03M(+181.3%)
-$10.37M(+10.9%)
-$37.03M(+13.6%)
Sep 2014
-
-$9.35M(+22.7%)
-$32.61M(+20.6%)
Jun 2014
-
-$7.62M(-21.4%)
-$27.03M(+21.5%)
Mar 2014
-
-$9.70M(+63.0%)
-$22.24M(+68.9%)
Dec 2013
-$13.17M(+60.7%)
-$5.95M(+57.9%)
-$13.17M(+82.4%)
Sep 2013
-
-$3.77M(+33.1%)
-$7.22M(+109.2%)
Jun 2013
-
-$2.83M(+355.9%)
-$3.45M(+455.9%)
Mar 2013
-
-$620.90K
-$620.90K
Dec 2012
-$8.20M
-
-

FAQ

  • What is Akebia Therapeutics annual net profit?
  • What is the all time high annual net income for Akebia Therapeutics?
  • What is Akebia Therapeutics annual net income year-on-year change?
  • What is Akebia Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Akebia Therapeutics?
  • What is Akebia Therapeutics quarterly net income year-on-year change?
  • What is Akebia Therapeutics TTM net profit?
  • What is the all time high TTM net income for Akebia Therapeutics?
  • What is Akebia Therapeutics TTM net income year-on-year change?

What is Akebia Therapeutics annual net profit?

The current annual net income of AKBA is -$69.41M

What is the all time high annual net income for Akebia Therapeutics?

Akebia Therapeutics all-time high annual net profit is -$8.20M

What is Akebia Therapeutics annual net income year-on-year change?

Over the past year, AKBA annual net profit has changed by -$17.48M (-33.67%)

What is Akebia Therapeutics quarterly net profit?

The current quarterly net income of AKBA is $6.11M

What is the all time high quarterly net income for Akebia Therapeutics?

Akebia Therapeutics all-time high quarterly net profit is $29.45M

What is Akebia Therapeutics quarterly net income year-on-year change?

Over the past year, AKBA quarterly net profit has changed by +$24.10M (+133.98%)

What is Akebia Therapeutics TTM net profit?

The current TTM net income of AKBA is -$45.31M

What is the all time high TTM net income for Akebia Therapeutics?

Akebia Therapeutics all-time high TTM net profit is -$620.90K

What is Akebia Therapeutics TTM net income year-on-year change?

Over the past year, AKBA TTM net profit has changed by -$2.28M (-5.30%)
On this page